BioCentury | Apr 28, 2014
Clinical News

AdipoCell: Clinical trial started

...trial for congestive heart failure (CHF). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Apr 14, 2014
Clinical News

AdipoCell: Clinical trial started

...trial for congestive heart failure (CHF). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Mar 24, 2014
Clinical News

AdipoCell: Additional Phase I data

...September (see BioCentury, Oct. 14, 2013). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Oct 14, 2013
Clinical News

Adipose-derived stem cells: Preliminary Phase I data

...Bioheart said is considered "clinically meaningful." Last month, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Sep 30, 2013
Company News

Bioheart, Invitrx deal

...Invitrx granted Bioheart rights to Invitrx's adipose derived stem cell products for use in all indications...
...declined to disclose details, and Invitrx could not be reached. Bioheart Inc. (OTCBB:BHRT), Sunrise, Fla. Invitrx Therapeutics Inc....
Items per page:
1 - 5 of 5
BioCentury | Apr 28, 2014
Clinical News

AdipoCell: Clinical trial started

...trial for congestive heart failure (CHF). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Apr 14, 2014
Clinical News

AdipoCell: Clinical trial started

...trial for congestive heart failure (CHF). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Mar 24, 2014
Clinical News

AdipoCell: Additional Phase I data

...September (see BioCentury, Oct. 14, 2013). Last year, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Oct 14, 2013
Clinical News

Adipose-derived stem cells: Preliminary Phase I data

...Bioheart said is considered "clinically meaningful." Last month, Invitrx Therapeutics Inc. (Irvine, Calif.) granted Bioheart rights to Invitrx's...
BioCentury | Sep 30, 2013
Company News

Bioheart, Invitrx deal

...Invitrx granted Bioheart rights to Invitrx's adipose derived stem cell products for use in all indications...
...declined to disclose details, and Invitrx could not be reached. Bioheart Inc. (OTCBB:BHRT), Sunrise, Fla. Invitrx Therapeutics Inc....
Items per page:
1 - 5 of 5